Pharmaron Beijing Revenue

In the year 2024, Pharmaron Beijing had annual revenue of 12.28B CNY with 6.39% growth. Pharmaron Beijing had revenue of 3.46B in the quarter ending December 31, 2024, with 16.15% growth.

Revenue

12.28B

Revenue Growth

+6.39%

P/S Ratio

3.92

Revenue / Employee

574.44K

Employees

20,295

Market Cap

44.56B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	12.28B	737.78M	6.39%
Dec 31, 2023	11.54B	1.27B	12.39%
Jan 1, 2023	10.27B	2.82B	37.92%
Dec 31, 2021	7.44B	2.31B	45.00%
Dec 31, 2020	5.13B	1.38B	36.64%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	26.00B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Yunnan Baiyao Group Co.,Ltd	39.34B
Shanghai United Imaging Healthcare	10.30B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings